These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


423 related items for PubMed ID: 9708542

  • 1. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
    Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, Noda M.
    Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
    [Abstract] [Full Text] [Related]

  • 2. Conduction block in acute motor axonal neuropathy.
    Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N.
    Brain; 2010 Oct; 133(10):2897-908. PubMed ID: 20855419
    [Abstract] [Full Text] [Related]

  • 3. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K, Sonoo M, Ogawa G, Kamakura K, Ueda-Sada M, Arita M, Motoyoshi K, Kusunoki S.
    Neurology; 2008 Nov 18; 71(21):1683-90. PubMed ID: 19015484
    [Abstract] [Full Text] [Related]

  • 4. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N.
    Ann Neurol; 2000 Oct 18; 48(4):624-31. PubMed ID: 11026446
    [Abstract] [Full Text] [Related]

  • 5. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
    Hiraga A, Kuwabara S, Ogawara K, Misawa S, Kanesaka T, Koga M, Yuki N, Hattori T, Mori M.
    Neurology; 2005 Mar 08; 64(5):856-60. PubMed ID: 15753422
    [Abstract] [Full Text] [Related]

  • 6. Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
    Nachamkin I, Arzarte Barbosa P, Ung H, Lobato C, Gonzalez Rivera A, Rodriguez P, Garcia Briseno A, Cordero LM, Garcia Perea L, Perez JC, Ribera M, Aldama PC, Guitérrez GD, Sarnat LF, García MR, Veitch J, Fitzgerald C, Cornblath DR, Rodriguez Pinto M, Griffin JW, Willison HJ, Asbury AK, McKhann GM.
    Neurology; 2007 Oct 23; 69(17):1665-71. PubMed ID: 17898327
    [Abstract] [Full Text] [Related]

  • 7. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
    Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, Dalakas MC.
    Ann Neurol; 1995 Aug 23; 38(2):218-24. PubMed ID: 7654069
    [Abstract] [Full Text] [Related]

  • 8. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Kornberg AJ, Pestronk A, Bieser K, Ho TW, McKhann GM, Wu HS, Jiang Z.
    Ann Neurol; 1994 Feb 23; 35(2):234-7. PubMed ID: 8109905
    [Abstract] [Full Text] [Related]

  • 9. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
    Yuki N, Kuwabara S.
    J Peripher Nerv Syst; 2007 Dec 23; 12(4):238-49. PubMed ID: 18042134
    [Abstract] [Full Text] [Related]

  • 10. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies.
    Yuki N, Yoshino H, Sato S, Shinozawa K, Miyatake T.
    Muscle Nerve; 1992 Aug 23; 15(8):899-903. PubMed ID: 1495505
    [Abstract] [Full Text] [Related]

  • 11. The refractory period of transmission is impaired in axonal Guillain-Barré syndrome.
    Kuwabara S, Bostock H, Ogawara K, Sung JY, Kanai K, Mori M, Hattori T, Burke D.
    Muscle Nerve; 2003 Dec 23; 28(6):683-9. PubMed ID: 14639581
    [Abstract] [Full Text] [Related]

  • 12. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A, Shahrizaila N, Salhi H, Lefaucheur JP, Yuki N.
    J Peripher Nerv Syst; 2014 Jun 23; 19(2):115-20. PubMed ID: 24750296
    [Abstract] [Full Text] [Related]

  • 13. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer.
    Harvey GK, Toyka KV, Zielasek J, Kiefer R, Simonis C, Hartung HP.
    Muscle Nerve; 1995 Apr 23; 18(4):388-94. PubMed ID: 7715623
    [Abstract] [Full Text] [Related]

  • 14. Cerebellar ataxia and acute motor axonal neuropathy associated with Anti GD1b and Anti GM1 antibodies.
    Bae JS, Kim BJ.
    J Clin Neurosci; 2005 Sep 23; 12(7):808-10. PubMed ID: 16054817
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV.
    Ann Neurol; 1998 Nov 23; 44(5):780-8. PubMed ID: 9818934
    [Abstract] [Full Text] [Related]

  • 16. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
    Rees JH, Gregson NA, Hughes RA.
    Ann Neurol; 1995 Nov 23; 38(5):809-16. PubMed ID: 7486873
    [Abstract] [Full Text] [Related]

  • 17. Motor and sensory conduction failure in overlap of Guillain-Barré and Miller Fisher syndrome: two simultaneous cases.
    Rajabally YA, Hassan-Smith G, Notturno F, Eames PJ, Hayton T, Capasso M, Uncini A.
    J Neurol Sci; 2011 Apr 15; 303(1-2):35-8. PubMed ID: 21316711
    [Abstract] [Full Text] [Related]

  • 18. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
    Yuki N, Yamada M, Sato S, Ohama E, Kawase Y, Ikuta F, Miyatake T.
    Muscle Nerve; 1993 Jun 15; 16(6):642-7. PubMed ID: 8502262
    [Abstract] [Full Text] [Related]

  • 19. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes.
    Kuwabara S, Ogawara K, Sung JY, Mori M, Kanai K, Hattori T, Yuki N, Lin CS, Burke D, Bostock H.
    Ann Neurol; 2002 Aug 15; 52(2):180-7. PubMed ID: 12210788
    [Abstract] [Full Text] [Related]

  • 20. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G, Kaida K, Kuwahara M, Kimura F, Kamakura K, Kusunoki S.
    J Neuroimmunol; 2013 Jan 15; 254(1-2):141-5. PubMed ID: 23000056
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.